Next, pan-cancer and gene-specific dN:dS ratios showed that HLA-A and HLA-B, but not HLC-C, are positively selected and are mostly enriched in truncating variants but not in missense mutations (Fig. 4b,c). This evidence concerns the gene HLA-A and cancer.